GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortress Biotech Inc (FRA:CNB1) » Definitions » Other Gross PPE

Fortress Biotech (FRA:CNB1) Other Gross PPE : €27.27 Mil (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Fortress Biotech Other Gross PPE?

Fortress Biotech's Other Gross PPE for the quarter that ended in Mar. 2024 was €27.27 Mil.

Fortress Biotech's quarterly Other Gross PPE declined from Sep. 2023 (€28.75 Mil) to Dec. 2023 (€27.66 Mil) and declined from Dec. 2023 (€27.66 Mil) to Mar. 2024 (€27.27 Mil).

Fortress Biotech's annual Other Gross PPE increased from Dec. 2021 (€28.48 Mil) to Dec. 2022 (€31.31 Mil) but then declined from Dec. 2022 (€31.31 Mil) to Dec. 2023 (€27.66 Mil).


Fortress Biotech Other Gross PPE Historical Data

The historical data trend for Fortress Biotech's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortress Biotech Other Gross PPE Chart

Fortress Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.75 25.54 28.48 31.31 27.66

Fortress Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.49 28.73 28.75 27.66 27.27

Fortress Biotech Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Fortress Biotech (FRA:CNB1) Business Description

Traded in Other Exchanges
Address
1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Fortress Biotech (FRA:CNB1) Headlines

No Headlines